Sound Shore Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $92M | Buy |
3,820,117
+949,696
| +33% | +$24.8M | 2.83% | 10 |
|
|
2026
Q1 | $80.6M | Buy |
+2,870,421
| New | +$76.4M | 2.7% | 12 |
|
|
2024
Q4 | – | Sell |
-2,748,790
| Closed | -$79.5M | – | 49 |
|
|
2024
Q3 | $79.5M | Sell |
2,748,790
-87,267
| -3% | -$2.55M | 2.59% | 18 |
|
|
2024
Q2 | $79.4M | Buy |
2,836,057
+279,825
| +11% | +$7.7M | 2.65% | 18 |
|
|
2024
Q1 | $70.9M | Buy |
2,556,232
+937,326
| +58% | +$26M | 2.22% | 28 |
|
|
2023
Q4 | $46.6M | Sell |
1,618,906
-46,741
| -3% | -$1.41M | 1.62% | 36 |
|
|
2023
Q3 | $55.2M | Sell |
1,665,647
-126,900
| -7% | -$4.49M | 2.12% | 33 |
|
|
2023
Q2 | $65.8M | Sell |
1,792,547
-647,521
| -27% | -$25.2M | 2.42% | 25 |
|
|
2023
Q1 | $99.6M | Buy |
2,440,068
+558,190
| +30% | +$24.1M | 3.75% | 4 |
|
|
2022
Q4 | $96.4M | Buy |
1,881,878
+120,072
| +7% | +$5.76M | 3.63% | 7 |
|
|
2022
Q3 | $77.1M | Buy |
1,761,806
+555,152
| +46% | +$27M | 3.12% | 15 |
|
|
2022
Q2 | $63.3M | Sell |
1,206,654
-757,555
| -39% | -$38.6M | 2.32% | 26 |
|
|
2022
Q1 | $102M | Sell |
1,964,209
-348,776
| -15% | -$18.1M | 2.95% | 15 |
|
|
2021
Q4 | $137M | Buy |
2,312,985
+420,184
| +22% | +$20.8M | 3.79% | 5 |
|
|
2021
Q3 | $81.4M | Sell |
1,892,801
-706,577
| -27% | -$31.3M | 2.3% | 31 |
|
|
2021
Q2 | $102M | Buy |
2,599,378
+417,045
| +19% | +$16.2M | 2.83% | 12 |
|
|
2021
Q1 | $79.1M | Sell |
2,182,333
-64,682
| -3% | -$2.3M | 2.31% | 22 |
|
|
2020
Q4 | $82.7M | Sell |
2,247,015
-591,645
| -21% | -$21.7M | 2.46% | 18 |
|
|
2020
Q3 | $98.8M | Sell |
2,838,660
-826,517
| -23% | -$29M | 3.09% | 8 |
|
|
2020
Q2 | $114M | Buy |
3,665,177
+122,162
| +3% | +$4.15M | 3.5% | 9 |
|
|
2020
Q1 | $110M | Buy |
3,543,015
+1,130,870
| +47% | +$38.5M | 3.82% | 7 |
|
|
2019
Q4 | $89.7M | Buy |
+2,412,145
| New | +$85.9M | 2.09% | 30 |
|
|
2019
Q3 | – | Sell |
-3,336,692
| Closed | -$137M | – | 38 |
|
|
2019
Q2 | $137M | Sell |
3,336,692
-130,537
| -4% | -$5.18M | 2.66% | 19 |
|
|
2019
Q1 | $140M | Sell |
3,467,229
-6,974
| -0.2% | -$279K | 2.69% | 21 |
|
|
2018
Q4 | $144M | Sell |
3,474,203
-2,156,114
| -38% | -$89.5M | 2.96% | 13 |
|
|
2018
Q3 | $235M | Sell |
5,630,317
-215,705
| -4% | -$8.3M | 4.02% | 3 |
|
|
2018
Q2 | $201M | Sell |
5,846,022
-211,428
| -3% | -$7.23M | 3.38% | 6 |
|
|
2018
Q1 | $204M | Sell |
6,057,450
-101,086
| -2% | -$3.48M | 3.3% | 6 |
|
|
2017
Q4 | $212M | Buy |
6,158,536
+532,053
| +9% | +$18.1M | 3.22% | 6 |
|
|
2017
Q3 | $191M | Buy |
5,626,483
+615,745
| +12% | +$19.8M | 3.11% | 11 |
|
|
2017
Q2 | $160M | Sell |
5,010,738
-1,121,109
| -18% | -$35.4M | 2.62% | 22 |
|
|
2017
Q1 | $199M | Buy |
6,131,847
+838,527
| +16% | +$26.4M | 3.3% | 6 |
|
|
2016
Q4 | $163M | Sell |
5,293,320
-66,331
| -1% | -$2.02M | 2.81% | 15 |
|
|
2016
Q3 | $172M | Buy |
5,359,651
+659,612
| +14% | +$22.1M | 3.07% | 8 |
|
|
2016
Q2 | $157M | Buy |
4,700,039
+185,762
| +4% | +$5.93M | 2.88% | 6 |
|
|
2016
Q1 | $127M | Buy |
+4,514,277
| New | +$129M | 2.31% | 33 |
|
|
2013
Q4 | – | Sell |
-8,432
| Closed | -$230K | – | 59 |
|
|
2013
Q3 | $230K | Sell |
8,432
-3,347,828
| -100% | -$91.1M | ﹤0.01% | 57 |
|
|
2013
Q2 | $89.2M | Buy |
+3,356,260
| New | +$92.7M | 1.74% | 40 |
|
Other funds holding PFE
Sound Shore Management's PFE Position: Q2 2026 in Review
Sound Shore Management increased its Pfizer (PFE) stake by 33% in Q2 2026, buying an estimated $24.8M and bringing the position to 3,820,117 shares worth $92M. The position accounts for 2.83% of the portfolio, ranked #10.
Sound Shore Management first reported a position in PFE in Q2 2013 and has held it in 38 quarters since. The position peaked at $235M in Q3 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Sound Shore Management held 3,820,117 shares of Pfizer worth $92M as of Q2 2026.
- Sound Shore Management bought 949,696 Pfizer shares in Q2 2026, an estimated $24.8M.
- Pfizer made up 2.83% of Sound Shore Management's portfolio in Q2 2026, its #10 holding.
- Sound Shore Management first reported a position in Pfizer in Q2 2013 and has held it in 38 quarters since.
- Sound Shore Management's Pfizer position peaked at $235M in Q3 2018.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Sound Shore Management's 13F filing for Q2 2026, filed 12 Aug 2026.